Published 1 day ago • loading... • Updated 9 hours agoShow Less IconWhy Analysts Are Divided Over Circle (CRCL) Stock Summary by Barchart.comCircle receives conflicting research notes from TD Cowen and Morgan Stanley analysts. Here’s what the two firms argued in their respective research reports.Share menu2 Articles2 ArticlesAllLeft1CenterRightSearch IconSort IconThe Motley FoolLean LeftFactualityOwnershipWhy Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech StockThe company is on the verge of becoming a commercial-stage biotech, with two promising therapies in phase 3 trials.1 day ago·Alexandria, United StatesRead Full ArticleBarchart.comFactualityOwnershipWhy Analysts Are Divided Over Circle (CRCL) StockCircle receives conflicting research notes from TD Cowen and Morgan Stanley analysts. Here’s what the two firms argued in their respective research reports.9 hours ago·Chicago, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources2Leaning Left1Leaning Right0Center0Last Updated56 minutes agoBias Distribution100% LeftBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources lean Left100% LeftL 100%Untracked biasFactuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageThe Motley Fool broke the news in Alexandria, United States 1 day ago on Sunday, August 2, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsMorgan Stanley Plus IconCircle Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsMorgan Stanley Plus IconCircle Plus IconShow All